Dutch ingredients Firm Vivici Partners With Ginkgo Bioworks For Alternative Protein Development

Dutch B2B ingredients company Vivici BV has partnered with biotech company Ginkgo Bioworks Holdings Inc DNA to develop and commercialize the next generation of functional alternative protein.

Recognizing the need for alternatives to traditional animal agriculture, Vivici employs precision fermentation techniques to produce animal-free dairy proteins with microorganisms.

Ginkgo is expected to support Vivici by providing optimized strains for dairy protein production via precision fermentation.

Ginkgo intends to design and build an integrated library, screen for strains with the best protein expression, validate and grow the most promising hits, and transfer the top-performing strains to Vivici for evaluation. 

Ginkgo will use its Protein Production Services and generative AI platform to deliver candidate strains to Vivici.

Vivici will use the strains from Ginkgo to extend their existing range of proteins, supporting specialized nutrition companies, to bring planet-friendly nutrition to consumers.

"We're here to help Vivici deliver on the promise that precision fermentation can lead to planet-friendly nutrition," said Kevin Madden, Senior Vice President of Commercialization at Ginkgo Bioworks.

Price Action: DNA shares are trading down by 0.68% at $1.45 in premarket on the last check Monday.